For a seven year period clinical and epidemiological data were prospectively collected on children aged <10 years with microbiologically confirmed invasive Haemophilus influenzae type b infection in the Oxford region to study the epidemiology of the disease and determine the potential impact of early primary immunisation in infints. Computer records of primary immunisations given to these cases were retrospectively analysed and, where necessary, hospital and general practitioner records were searched to determine the immunisation history.
against H influenzae type b began in 1991 as part of a regional trial. The estimated annual incidence for invasive disease between 1985 and 1990 was 35 5 cases per 100 000 children aged less than 5 years; for H influenzae type b meningitis it was 25-1 per 100 000 children aged less than 5 years. The cumulative risks for invasive disease and meningitis by the fifth birthday were one in 560 and one in 800 respectively. The majority of disease (71%) occurred in children less than 2 years of age with the peak monthly incidences at 6 and 7 months ofage. The overall mortality was 4*3%/ and 50%/o of these deaths occurred suddenly. Most [225] [226] [227] [228] Haemophilus influenzae type b is a major cause of serious bacterial infection in early childhood. Throughout the 1980s and early 1990s this organism has consistently been the most frequent cause of bacterial meningitis in children reported from microbiology laboratories in England and Wales. 1 Infants are protected for the first few months after birth by maternal antibodies and to a lesser extent by breast feeding.2 3 However, the peak incidence of disease occurs later in the first year when the concentration of antibodies against the type b capsule, polyribisol ribitol phosphate (PRP), is at its lowest.2
The first effective vaccine consisted of purified PRP but was only protective in children older than 18 months of age. (12; 28 (7) years of age (98%) and 295 <2 years (71%).
Disease incidence was highest in those < 1 year of age and the peak monthly incidence occurred jointly at 6 and 7 months of age (figure). In keeping with similar surveys,9 10 infection was more common in the cooler months with 53% of cases occurring in the five months from October to February.
Overall, boys were more commonly affected than girls (1 33: 1) and this held true separately for meningitis (1-20:1), epiglottitis (1-40:1), and a combination of the other infections (1 17:1).
There have been 18 deaths: 14 resulting from meningitis, three from epiglottitis, and one from bacteraemia, giving an overall mortality of 4.3% and a mortality for meningitis of 4-8%. The age range of deaths was 2 months-5 years with a median of 15 months. Only two infants were aged <5 months. The 15 (4) Age (months) 8 (2) Distibution of H influenzae type b disease by age in 6 (1) months of the 181 cases occurring in the first year of life.
male:female ratio of deaths was 2:1. Nine (50%) of the deaths occurred suddenly with the child either being found dead at home or in cardiorespiratory arrest on arrival in casualty.
Ampicillin resistance, secondary to ,3 lactamase production, was found in 12-3% of isolates. None was chloramphenicol resistant. There was no significant difference in the rate of ampicillin resistance on comparison of isolates from 1985-7 with those from 1988-90 (p>0.3). The case fatality rate was similar whether or not an isolate was resistant to ampicillin: 6% versus 4% (p>0 3).
The history ofprimary immunisation against diphtheria, tetanus, and pertussis was determined in 401 (96%) children The incidence observed is remarkably similar to a recent report from Wales.9 A somewhat lower incidence of disease has been estimated from an extended UK survey that began in 1990 and encompasses, in addition to Oxford and Wales, four other English regional health authorities.'2 However, it is known that the degree of under reporting has been greater in the other English regions than in the Oxford region (personal communication, C MacLeod). As the annual live birth rate in the UK is about 790 000, we estimate that 1400 cases of invasive H influenzae type b disease and over 900 cases ofH influenzae type b meningitis occur annually in UK children aged <5 years.
The significantly lower incidence in 1991 is most likely due to natural fluctuation. It was too early to be a direct vaccine effect as only two cases were predicted to have been prevented by the end of 1991. It was unlikely to be an indirect effect either as there was an equivalent reduction in vaccine and control districts (43% v 32%). Furthermore, vaccine was only offered to children <6 months of age and yet there was an equal reduction in cases among those <1 year of age compared with those >1 year. Nationally, the number of laboratory reports was similar in 1990, 1991, and 1992 (1210, 1138, and 1088) 13 
